Results 1 to 10 of about 26,096 (186)

Contemporary NSTEMI management: the role of the hospitalist [PDF]

open access: yesHospital Practice (1995), 2020
Non-ST-segment elevation myocardial infarction (NSTEMI) is defined as elevated cardiac biomarkers of necrosis in the absence of persistent ST-segment elevation in the setting of anginal symptoms or other acute event. It carries a poorer prognosis than most ST-segment elevation events, owing to the typical comorbidity burden of the older NSTEMI patients

exaly   +3 more sources

The Effects of Allopurinol on Levels of Cardiac Troponin Following Non-ST Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial [PDF]

open access: yesPharmaceutical Sciences, 2021
Background: Given the potential anti-ischemic effects of allopurinol, we aimed to assess whether allopurinol administration may reduce myocardial injury following non-ST elevation myocardial infarction (NSTEMI). Methods: A randomized clinical trial (RCT)
Sajad Khiali   +5 more
doaj   +1 more source

Oxidants and antioxidants in myocardial infarction (MI): Investigation of ischemia modified albumin, malondialdehyde, superoxide dismutase and catalase in individuals diagnosed with ST elevated myocardial infarction (STEMI) and non-STEMI (NSTEMI) [PDF]

open access: yesJournal of Medical Biochemistry, 2021
Background: Coronary ischemia can lead to myocardial damage and necrosis. The pathogenesis of cardiovascular diseases often includes increased oxidative stress and decreased antioxidant defense.
Aladağ Nesim   +6 more
doaj   +1 more source

Acute myocardial infarction at a district hospital in KwaZulu-Natal – Management and outcomes

open access: yesSouth African Family Practice, 2022
Background: Acute myocardial infarction (AMI) following ischaemic heart disease (IHD) is associated with increased morbidity and mortality. The condition remains a management challenge in resource-constrained environments.
Zakariya Badat, Selvandran Rangiah
doaj   +1 more source

Management of Acute Coronary Syndrome in the COVID Era

open access: yesMethodist DeBakey Cardiovascular Journal, 2021
Management of acute coronary syndrome (ACS) has emerged as a challenge during the COVID-19 era. There has been a significant increase in the morbidity and mortality associated with ACS both as a direct and an indirect consequence of the pandemic. In this
Ronak Bahuva, Joe Aoun, Sachin S. Goel
doaj   +1 more source

Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction

open access: yesPLoS ONE, 2021
Background The detailed causes of death in non–ST-segment–elevation myocardial infarction (NSTEMI) have not been adequately evaluated compared to those in ST-segment elevation myocardial infarction (STEMI).
Yasuaki Takeji   +27 more
doaj   +2 more sources

Vascular senescence and atherosclerotic plaque vulnerability: investigating the telomere-mitochondria crosstalk—rationale and design of the VICTORIA Study [PDF]

open access: yesExploration of Cardiology
Vascular aging is recognized as one of the hallmarks of atherosclerosis. Currently, a growing body of evidence suggests that there exists a mutual crosstalk between telomere dysfunction and mitochondrial dysmetabolism during the process of vascular ...
Jonica Campolo   +11 more
doaj   +1 more source

High medium-term incidence of major cardiovascular events in discharged patients with unstable angina

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2023
The introduction of high-sensitivity troponin (hsTn) assays has reduced the diagnosis of unstable angina (UA) in favor of non-ST elevation myocardial infarction (NSTEMI) in the context of non-ST elevation acute coronary syndrome (NSTEACS).
Marta Herrero-Brocal   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy